Theresa M Winhusen1, Frankie Kropp2, Jeff Theobald2, Daniel F Lewis2. 1. Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3210 Jefferson Avenue, Cincinnati, OH 45220, USA. Electronic address: winhust@ucmail.uc.edu. 2. Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3210 Jefferson Avenue, Cincinnati, OH 45220, USA.
Abstract
BACKGROUND: Past research suggests that a significant relationship exists between cigarette smoking and illicit-stimulant abuse. The present study evaluated the association between achieving smoking abstinence in response to smoking-cessation treatment (SCT) and illicit-stimulant abstinence in cocaine- and/or methamphetamine-dependent participants. METHODS: Secondary analysis of a randomized, 10-week trial conducted at 12 substance use disorder (SUD) treatment programs. Two hundred and sixty seven adults, meeting DSM-IV-TR criteria for cocaine and/or methamphetamine-dependence and interested in quitting smoking were randomized to SUD treatment as usual plus SCT consisting of weekly individual smoking cessation counseling, extended-release (XL) bupropion (300 mg/day), nicotine inhaler, and contingency management for smoking abstinence. Illicit-stimulant-abstinence was measured by self-report and urine drug screens. Smoking abstinence was assessed via self-report and carbon monoxide levels. RESULTS: A significant effect was found for the cocaine-dependent subsample (N=147) in which participants who stopped smoking were abstinent for illicit stimulants an average of 78.2% of the post-smoking-quit weeks (weeks 4-10) relative to 63.6% in participants who continued smoking (X(2)(1)=8.55, p<.01, d=0.36). No significant effects were found for the sample as a whole (N=249) or for the methamphetamine-dependent subsample (N=102). CONCLUSIONS: The present results suggest that cocaine-dependent patients achieving smoking abstinence in response to SCT might evidence not only improved smoking outcomes but improved cocaine-use outcomes as well. Future research to replicate this finding appears warranted.
RCT Entities:
BACKGROUND: Past research suggests that a significant relationship exists between cigarette smoking and illicit-stimulant abuse. The present study evaluated the association between achieving smoking abstinence in response to smoking-cessation treatment (SCT) and illicit-stimulant abstinence in cocaine- and/or methamphetamine-dependent participants. METHODS: Secondary analysis of a randomized, 10-week trial conducted at 12 substance use disorder (SUD) treatment programs. Two hundred and sixty seven adults, meeting DSM-IV-TR criteria for cocaine and/or methamphetamine-dependence and interested in quitting smoking were randomized to SUD treatment as usual plus SCT consisting of weekly individual smoking cessation counseling, extended-release (XL) bupropion (300 mg/day), nicotine inhaler, and contingency management for smoking abstinence. Illicit-stimulant-abstinence was measured by self-report and urine drug screens. Smoking abstinence was assessed via self-report and carbon monoxide levels. RESULTS: A significant effect was found for the cocaine-dependent subsample (N=147) in which participants who stopped smoking were abstinent for illicit stimulants an average of 78.2% of the post-smoking-quit weeks (weeks 4-10) relative to 63.6% in participants who continued smoking (X(2)(1)=8.55, p<.01, d=0.36). No significant effects were found for the sample as a whole (N=249) or for the methamphetamine-dependent subsample (N=102). CONCLUSIONS: The present results suggest that cocaine-dependent patients achieving smoking abstinence in response to SCT might evidence not only improved smoking outcomes but improved cocaine-use outcomes as well. Future research to replicate this finding appears warranted.
Authors: A Margolin; T R Kosten; S K Avants; J Wilkins; W Ling; M Beckson; I O Arndt; J Cornish; J A Ascher; S H Li Journal: Drug Alcohol Depend Date: 1995-12 Impact factor: 4.492
Authors: Ashwin A Patkar; Michael J Vergare; Charles C Thornton; Stephen P Weinstein; Heather W Murray; Frank T Leone Journal: Nicotine Tob Res Date: 2003-06 Impact factor: 4.244
Authors: Richard D Hurt; James E Krook; Ivana T Croghan; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; Carl G Kardinal; James A Knost; Maria Tria Tirona; Ferdinand Addo; Roscoe F Morton; John C Michalak; Paul L Schaefer; Patricia A Porter; Philip J Stella Journal: J Clin Oncol Date: 2003-03-01 Impact factor: 44.544
Authors: Ned L Cooney; Mark D Litt; Kevin A Sevarino; Lucienne Levy; Linda S Kranitz; Helen Sackler; Judith L Cooney Journal: J Consult Clin Psychol Date: 2015-01-26
Authors: R Kathryn McHugh; Victoria R Votaw; Francesca Fulciniti; Hilary S Connery; Margaret L Griffin; Peter M Monti; Roger D Weiss Journal: J Subst Abuse Treat Date: 2016-12-30
Authors: Elizabeth Reisinger Walker; Laura A Pratt; Charlotte A Schoenborn; Benjamin G Druss Journal: Drug Alcohol Depend Date: 2016-11-24 Impact factor: 4.492
Authors: Andrea H Weinberger; Misato Gbedemah; Melanie M Wall; Deborah S Hasin; Michael J Zvolensky; Renee D Goodwin Journal: Addiction Date: 2017-12-19 Impact factor: 6.526
Authors: Sharon A Fitzgerald; Kimber P Richter; Laura Mussulman; Eric Howser; Shadi Nahvi; Kathy Goggin; Nina A Cooperman; Babalola Faseru Journal: Jt Comm J Qual Patient Saf Date: 2016-05